跳至主要内容
临床试验/IRCT20170609034406N9
IRCT20170609034406N9招募中3 期

The effect of probiotic and zinc combination therapy for the prevention of recurrence of Hepatic encephalopathy (secondary prophylaxis) in cirrhotic patients

Tabriz University of Medical Sciences0 个研究点目标入组 120 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
入组人数
120

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 80 years(—)
性别
All

入选标准

  • Patients between ages 18 and 80 years
  • Cirrhotic patients who had recovered from an episode of overt hepatic encephalopathy

排除标准

  • Patients on probiotic therapy
  • History of alcohol intake during the past 6 weeks
  • Active infection at the time of enrollment in the study
  • Previous transjugular intrahepatic portosystemic shunt or shunt surgery
  • Renal failure
  • Use of psychoactive drugs, such as antidepressants or sedatives
  • Any neurologic diseases, such as Alzheimer’s disease, Parkinson’s disease, and Non hepatic metabolic encephalopathies

研究者

相似试验